X

JAKAVI TABLET 10MG

Product Information

Registration Status: Active

SIN14927P

JAKAVI TABLET 10MG is approved to be sold in Singapore with effective from 2016-01-25. It is marketed by NOVARTIS (SINGAPORE) PTE LTD, with the registration number of SIN14927P.

This product contains Ruxolinitib 10mg in the form of TABLET. It is approved for ORAL use.

This product is manufactured by Novartis Pharma Stein AG in SWITZERLAND.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...



Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!